Poniard Pharmaceuticals Financials

PARDDelisted Stock  USD 0.01  0.00  0.00%   
We recommend to use Poniard Pharmaceuticals fundamental analysis to find out if markets are presently mispricing the firm. Put it differently this technique allows you to confirm available drivers of Poniard Pharmaceuticals as well as the relationship between them. We were able to interpolate data for thirty available financial ratios for Poniard Pharmaceuticals, which can be compared to its competitors. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Poniard Pharmaceuticals to be traded at $0.0099 in 90 days.
  
Please note, the presentation of Poniard Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Poniard Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Poniard Pharmaceuticals' management manipulating its earnings.

Poniard Pharmaceuticals Stock Summary

Poniard Pharmaceuticals competes with Ikena Oncology, Xilio Development, Protara Therapeutics, Scholar Rock, and Crinetics Pharmaceuticals. Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington. PONIARD PHARMACEUT operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 7 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS7324494001
CUSIP732449400 732449301 640520300 732449103
LocationCalifornia; U.S.A
Business Address300 Elliott Avenue
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.poniard.com/
Phone206 281 7001
CurrencyUSD - US Dollar

Poniard Pharmaceuticals Key Financial Ratios

There are many critical financial ratios that Poniard Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Poniard Pharmaceuticals reports annually and quarterly.

Poniard Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Poniard Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Poniard Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Poniard Pharmaceuticals competition to find correlations between indicators driving Poniard Pharmaceuticals's intrinsic value. More Info.
Poniard Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Poniard Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Poniard Pharmaceuticals Market Pulse

 Quote0.01
 Change(%) 0.00  
 Change0.00 
 Open0.01
 Low0.01
 High0.01
 Volume0
 ExchangePINK
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Poniard Pink Sheet

If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities